All stories tagged :

Pr Newswire

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy...

admin
Pr Newswire

Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results

admin
Pr Newswire

Fennec Announces Results of Annual Meeting

admin
Pr Newswire

Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy...

admin
Pr Newswire

Jacobi releases Model Portfolio Tech to help investment firms capitalise on...

admin
Pr Newswire

HITACHI AIR CONDITIONING’S LATEST CUTTING-EDGE HVAC SOLUTIONS UNVEILED FOR AUSTRALIA AND...

admin
Pr Newswire

Venture Global Launches First Vessel from State-of-the-Art LNG Fleet

admin
Pr Newswire

More than 150,000 money laundering accounts detected in APAC

admin
Pr Newswire

LANZAJET ANNOUNCES STRATEGIC INVESTMENT FROM MUFG, JAPAN’S LEADING FINANCIAL GROUP

admin
Pr Newswire

Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual...

admin
Pr Newswire

EY Announces Eric Reimer of Healthmap Solutions as an Entrepreneur Of...

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...